Meye A - Search Results

1

Growth reduction of a xenotransplanted human soft tissue sarcoma by MDM2 antisense therapy via implanted osmotic minipumps.

Würl P, Bartel F, Meye A, Kappler M, Bache M, Schmidt H, Schönfelder M, Taubert H. Würl P, et al. Among authors: meye a. Int J Oncol. 2002 May;20(5):1087-93. Int J Oncol. 2002. PMID: 11956608

2

High bad and bcl-xL gene expression and combined bad, bcl-xL, bax and bcl-2 mRNA levels: molecular predictors for survival of stage 2 soft tissue sarcoma patients.

Köhler T, Würl P, Meye A, Lautenschläger C, Bartel F, Borchert S, Bache M, Schmidt H, Holzhausen HJ, Taubert H. Köhler T, et al. Among authors: meye a. Anticancer Res. 2002 May-Jun;22(3):1553-9. Anticancer Res. 2002. PMID: 12168836

3

Prognostic value of immunohistochemistry for p53 in primary soft-tissue sarcomas: a multivariate analysis of five antibodies.

Würl P, Taubert H, Meye A, Berger D, Lautenschläger C, Holzhausen HJ, Schmidt H, Kalthoff H, Rath FW, Dralle H. Würl P, et al. Among authors: meye a. J Cancer Res Clin Oncol. 1997;123(9):502-8. doi: 10.1007/BF01192205. J Cancer Res Clin Oncol. 1997. PMID: 9341900

4

Prognostic relevance of C-terminal Mdm2 detection is enhanced by p53 positivity in soft tissue sarcomas.

Würl P, Meye A, Berger D, Bache M, Lautenschläger C, Schmidt H, Kalthoff H, Rath FW, Taubert H. Würl P, et al. Among authors: meye a. Diagn Mol Pathol. 1997 Oct;6(5):249-54. doi: 10.1097/00019606-199710000-00001. Diagn Mol Pathol. 1997. PMID: 9458382

5

High prognostic significance of Mdm2/p53 co-overexpression in soft tissue sarcomas of the extremities.

Würl P, Meye A, Schmidt H, Lautenschläger C, Kalthoff H, Rath FW, Taubert H. Würl P, et al. Among authors: meye a. Oncogene. 1998 Mar 5;16(9):1183-5. doi: 10.1038/sj.onc.1201646. Oncogene. 1998. PMID: 9528860

6

Significance of retinoblastoma and mdm2 gene expression as prognostic markers for soft-tissue sarcoma.

Würl P, Meye A, Berger D, Lautenschläger C, Bache M, Holzhausen HJ, Schmidt H, Dralle H, Rath FW, Taubert H. Würl P, et al. Among authors: meye a. Langenbecks Arch Surg. 1998 Mar;383(1):99-103. doi: 10.1007/s004230050099. Langenbecks Arch Surg. 1998. PMID: 9627179

7

Molecular characterization and liposomal transfection of a p53-mutated cell line established from a poorly differentiated leiomyosarcoma.

Meye A, Bache M, Hinze R, Schmidt H, Würl P, Holzhausen HJ, Rath FW, Taubert H. Meye A, et al. Int J Oncol. 1998 Aug;13(2):241-8. doi: 10.3892/ijo.13.2.241. Int J Oncol. 1998. PMID: 9664117

8

Clinical relevance of pRb and p53 co-overexpression in soft tissue sarcomas.

Würl P, Meye A, Lautenschläger C, Schmidt H, Bache M, Kalthoff H, Schönfelder M, Rath FW, Taubert H. Würl P, et al. Among authors: meye a. Cancer Lett. 1999 May 24;139(2):159-65. doi: 10.1016/s0304-3835(99)00034-8. Cancer Lett. 1999. PMID: 10395173

9

Colony formation of soft tissue sarcoma cells is inhibited by lipid-mediated antisense oligodeoxynucleotides targeting the human mdm2 oncogene.

Meye A, Würl P, Bache M, Bartel F, Grünbaum U, Mansa-ard J, Schmidt H, Taubert H. Meye A, et al. Cancer Lett. 2000 Feb 28;149(1-2):181-8. doi: 10.1016/s0304-3835(99)00356-0. Cancer Lett. 2000. PMID: 10737722

10

mdm2 mRNA level is a prognostic factor in soft tissue sarcoma.

Taubert H, Koehler T, Meye A, Bartel F, Lautenschläger C, Borchert S, Bache M, Schmidt H, Würl P. Taubert H, et al. Among authors: meye a. Mol Med. 2000 Jan;6(1):50-9. Mol Med. 2000. PMID: 10803408 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

111 results

Search Page

Filters